Monday, April 2, 2007

UPDATE 1-Akorn says FDA move to hurt H1 sales by about $2 mln

(Reuters) - The company said the notice will affect the manufacture of IC-Green, its intravenous dye, which could hurt first-half 2007 revenue by about $2 million.

Akorn said it will immediately seek a contract manufacturer for IC-Green.


Read more at Reuters.com Government Filings News

No comments: